Artikel
The impact of pharmaceutical innovation on cancer mortality in Mexico, 2003-2013
I assess the impact that pharmaceutical innovation had on cancer mortality in Mexico during the period 2003-2013, by investigating whether there were larger declines in the age-standardized mortality rate of cancer sites (breast, lung, colon, etc.) that were subject to more pharmaceutical innovation, controlling for changes in the age-standardized cancer incidence rate. The estimates indicate that new drugs launched during 1991-2001 reduced the age-standardized cancer mortality rate by 16%, i.e., at an average annual rate of about 1.6%. I estimate that 105,661 life-years before age 70 were gained in 2013 due to cancer drugs launched during 1991-2001, and that the cost per life-year gained was in the neighborhood of $2146. By the standards of the World Health Organization, new cancer drugs have been very cost-effective in Mexico. The contribution of cancer drug innovation to Mexican longevity growth has been valuable, but, perhaps, it could have been even larger. Only half as many new cancer drugs were launched in Mexico during 2010-2014 as were launched in the US. In addition, when new drugs are launched in Mexico, their diffusion tends to be quite slow.
- Sprache
-
Englisch
- Erschienen in
-
Journal: Latin American Economic Review ; ISSN: 2196-436X ; Volume: 26 ; Year: 2017 ; Issue: 1 ; Pages: 1-22 ; Heidelberg: Springer
- Klassifikation
-
Wirtschaft
Demographic Trends, Macroeconomic Effects, and Forecasts
Chemicals; Rubber; Drugs; Biotechnology; Plastics
Technological Change: Choices and Consequences; Diffusion Processes
- Thema
-
Pharmaceutical
Innovation
Mortality
Longevity
Cancer
Mexico
Cost-effectiveness
- Ereignis
-
Geistige Schöpfung
- (wer)
-
Lichtenberg, Frank R.
- Ereignis
-
Veröffentlichung
- (wer)
-
Springer
- (wo)
-
Heidelberg
- (wann)
-
2017
- DOI
-
doi:10.1007/s40503-017-0045-6
- Handle
- Letzte Aktualisierung
-
10.03.2025, 11:44 MEZ
Datenpartner
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Artikel
Beteiligte
- Lichtenberg, Frank R.
- Springer
Entstanden
- 2017
Ähnliche Objekte (12)
Pharmaceutical aspects of cancer care
The association between pharmaceutical innovation and both premature mortality and hospital utilization in Switzerland, 1996-2019
Second generation patents in pharmaceutical innovation
Leading pharmaceutical innovation : trends and drivers for growth in the pharmaceutical industry
Collaboration and innovation in the pharmaceutical industry
Pharmaceutical innovation, incremental patenting and compulsory licensing
Private versus Social Incentives for Pharmaceutical Innovation
Spatio-Temporal Models on the Basis of Innovation Processes and Application to Cancer Mortality Data
Spatio-temporal models on the basis of innovation processes and application to cancer mortality data
Atlas of cancer mortality in Poland : 1975 - 1979
Suicide risk and mortality among patients with cancer
Mortality shocks and household consumption: The case of Mexico
Pharmaceutical aspects of cancer care
The association between pharmaceutical innovation and both premature mortality and hospital utilization in Switzerland, 1996-2019
Second generation patents in pharmaceutical innovation
Leading pharmaceutical innovation : trends and drivers for growth in the pharmaceutical industry
Collaboration and innovation in the pharmaceutical industry
Pharmaceutical innovation, incremental patenting and compulsory licensing
Private versus Social Incentives for Pharmaceutical Innovation
Spatio-Temporal Models on the Basis of Innovation Processes and Application to Cancer Mortality Data
Spatio-temporal models on the basis of innovation processes and application to cancer mortality data
Atlas of cancer mortality in Poland : 1975 - 1979
Suicide risk and mortality among patients with cancer
Mortality shocks and household consumption: The case of Mexico
Pharmaceutical aspects of cancer care
The association between pharmaceutical innovation and both premature mortality and hospital utilization in Switzerland, 1996-2019
Second generation patents in pharmaceutical innovation
Leading pharmaceutical innovation : trends and drivers for growth in the pharmaceutical industry
Collaboration and innovation in the pharmaceutical industry
Pharmaceutical innovation, incremental patenting and compulsory licensing
Private versus Social Incentives for Pharmaceutical Innovation
Spatio-Temporal Models on the Basis of Innovation Processes and Application to Cancer Mortality Data
Spatio-temporal models on the basis of innovation processes and application to cancer mortality data
Atlas of cancer mortality in Poland : 1975 - 1979
Suicide risk and mortality among patients with cancer